These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

141 related articles for article (PubMed ID: 1718588)

  • 1. Combination therapy: lonidamine, hyperthermia, and chemotherapy against the RIF-1 tumor in vivo.
    Ning SC; Hahn GM
    Cancer Res; 1991 Nov; 51(21):5910-4. PubMed ID: 1718588
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Lonidamine as a modulator of alkylating agent activity in vitro and in vivo.
    Teicher BA; Herman TS; Holden SA; Epelbaum R; Liu SD; Frei E
    Cancer Res; 1991 Feb; 51(3):780-4. PubMed ID: 1988117
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Cytotoxicity of lonidamine alone and in combination with other drugs against murine RIF-1 and human HT1080 cells in vitro.
    Ning SC; Hahn GM
    Cancer Res; 1990 Dec; 50(24):7867-70. PubMed ID: 2253227
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Sequencing of trimodality therapy [cis-diamminedichloroplatinum(II)/hyperthermia/radiation] as determined by tumor growth delay and tumor cell survival in the FSaIIC fibrosarcoma.
    Herman TS; Teicher BA
    Cancer Res; 1988 May; 48(10):2693-7. PubMed ID: 3359430
    [TBL] [Abstract][Full Text] [Related]  

  • 5. In vivo response of murine RIF tumors to thermochemotherapy.
    Neilan BA; Henle KJ
    J Med; 1989; 20(1):107-12. PubMed ID: 2468731
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Combined modality therapy with bleomycin, hyperthermia, and radiation.
    Teicher BA; Herman TS; Holden SA
    Cancer Res; 1988 Nov; 48(22):6291-7. PubMed ID: 2460220
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Responses of RIF tumors to heat and drugs: dependence on tumor size.
    Li DJ; Hahn GM
    Cancer Treat Rep; 1984 Sep; 68(9):1149-51. PubMed ID: 6206943
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Addition of 2-nitroimidazole radiosensitizers to cis-diamminedichloroplatinum(II) with radiation and with or without hyperthermia in the murine FSaIIC fibrosarcoma.
    Herman TS; Teicher BA; Holden SA; Pfeffer MR; Jones SM
    Cancer Res; 1990 May; 50(9):2734-40. PubMed ID: 2139359
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Optimizing the factors which modify thermal enhancement of melphalan in a spontaneous murine tumor.
    Mohamed F; Stuart OA; Glehen O; Urano M; Sugarbaker PH
    Cancer Chemother Pharmacol; 2006 Dec; 58(6):719-24. PubMed ID: 16614851
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Etoposide with lonidamine or pentoxifylline as modulators of alkylating agent activity in vivo.
    Tanaka J; Teicher BA; Herman TS; Holden SA; Dezube B; Frei E
    Int J Cancer; 1991 Jun; 48(4):631-7. PubMed ID: 2045206
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Interaction of SR-4233 with hyperthermia and radiation in the FSaIIC murine fibrosarcoma tumor system in vitro and in vivo.
    Herman TS; Teicher BA; Coleman CN
    Cancer Res; 1990 Aug; 50(16):5055-9. PubMed ID: 2379171
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Modification of tumor cell sensitivity to antineoplastic agents lonidamine and bouvardin (NSC 259968) at elevated temperatures.
    Adwankar MK; Chitnis MP
    Neoplasma; 1986; 33(2):217-23. PubMed ID: 3713924
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Interaction with hyperthermia of tetrachloroplatinum(II)(Nile blue)2 and tetrachloroplatinum(II)(neutral red)2 in EMT6 murine cells and the murine FSaIIC fibrosarcoma.
    Herman TS; Teicher BA; Pfeffer MR; Khandekar VS; Korbut TT
    Cancer Res; 1990 Jul; 50(13):3826-31. PubMed ID: 2354434
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Classification of antineoplastic treatments by their differential toxicity toward putative oxygenated and hypoxic tumor subpopulations in vivo in the FSaIIC murine fibrosarcoma.
    Teicher BA; Holden SA; al-Achi A; Herman TS
    Cancer Res; 1990 Jun; 50(11):3339-44. PubMed ID: 2334928
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Enhancing the antitumoral effect of hypericin-mediated photodynamic therapy by hyperthermia.
    Chen B; Roskams T; de Witte PA
    Lasers Surg Med; 2002; 31(3):158-63. PubMed ID: 12224088
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Response of mouse sarcoma-180 to cis-platin in combination with radiation & hyperthermia.
    Rao BS; Devi PU
    Indian J Med Res; 1996 Jun; 103():315-22. PubMed ID: 8707373
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Combination and individual antitumor effects of hyperthermia, cisplatin, and selected dithiocarbamates.
    Walker EM; Schaefer RF; Henle KJ; Schmidt BJ; Gale GR; Cannon DJ; Jones MM; Moss AJ
    Ann Clin Lab Sci; 1989; 19(4):242-54. PubMed ID: 2757352
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The antitumor effect of hyperthermia combined with fluorouracil and its analogues.
    Harada S; Ping L; Obara T; Oikawa H; Miyata M; Matsuo M; Takahashi T; Yanagisawa T
    Radiat Res; 1995 May; 142(2):232-41. PubMed ID: 7724740
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Cepharanthine enhances in vitro and in vivo thermosensitivity of a mouse fibrosarcoma, FSa-II, based on increased apoptosis.
    Wang Y; Kuroda M; Gao XS; Akaki S; Asaumi J; Okumura Y; Shibuya K; Kawasaki S; Joja I; Kato H; Himei K; Dendo S; Kanazawa S; Hiraki Y
    Int J Mol Med; 2004 Mar; 13(3):405-11. PubMed ID: 14767571
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Thermal behavior of a human glioma cell line and its response to combinations of hyperthermia and lonidamine.
    Floridi A; Gentile FP; Bruno T; Delpino A; Iacobini C; Paggi MG; Castiglione S; Benassi M
    Oncol Res; 1993; 5(1):1-10. PubMed ID: 8369571
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.